Company Filing History:
4 out of 106 
3 out of 174 
2 out of 3 Years Active: 2005-2020
Title: The Innovative Contributions of Michael John Bennett
Introduction
Michael John Bennett is a prominent inventor based in San Diego, California. He has made significant contributions to the field of epigenetics, particularly through his innovative work on bromodomain inhibitors. With a total of 11 patents to his name, Bennett's inventions are paving the way for advancements in cancer treatment.
Latest Patents
Bennett's latest patents focus on bromodomain inhibitors, which are substituted heterocyclic derivative compounds. These compounds and their compositions are designed for epigenetic regulation by inhibiting bromodomain-mediated recognition of acetyl lysine regions of proteins, such as histones. The methods and compositions developed by Bennett are particularly useful for the treatment of cancer and neoplastic diseases.
Career Highlights
Throughout his career, Michael John Bennett has worked with several notable companies, including Celgene, Quanticel Research, Inc., and Agouron Pharmaceuticals, Inc. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in the pharmaceutical industry.
Collaborations
Bennett has collaborated with several talented individuals in his field, including Jeffrey Alan Stafford and Amogh Boloor. These partnerships have further enhanced his innovative capabilities and have led to the development of impactful inventions.
Conclusion
Michael John Bennett's work exemplifies the spirit of innovation in the field of epigenetics. His contributions through patents and collaborations are making a significant impact on cancer treatment and research.